About Achieve

Achieve is a privately held specialty pharmaceutical company committed to advancing cytisine as a widely available treatment option to help people battling nicotine addiction. In January 2017, Achieve entered into a definitive merger agreement with OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) to create a global, clinical-stage company focused on development and commercialization of cytisine. To learn more about our company, please review our investor presentation.

Important Additional Information about the Proposed Merger